Madrigal Pharmaceuticals (MDGL)

Company Profile

madrigal pharmaceuticals inc. is a biotechnology company based out of calle laguna del marquesado nª 19, nave 16 edificio adriana 1ª planta, polígono industrial la resina (villaverde), madrid, community of madrid, spain.

Company profile

Ticker

MDGL

Exchange

NASDAQ

Website

www.madrigalpharma.com/

CEO

Rebecca Taub

Incorporated

Delaware

Location

Pennsylvania

Fiscal year end

Dec 31

Sector

Manufacturing > Pharmaceutical Preparation Manufacturing

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co • Teva- Pharmaceutical Industries • Bristol-Myers Squibb • Lilly(Eli) & Co • Viatris • Abbvie • Bausch Health Companies • Celgene ...

Former names

SYNTA PHARMACEUTICALS CORP

SEC CIK

0001157601

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

Madrigal Pharmaceuticals EU Limited, an Ireland company • Synta Limited Incorporated • Canticle Pharmaceuticals, Inc. ...

MDGL stock data

1M 1Y 5Y

Latest filings (excl ownership)

View all

8-K

Madrigal Pharmaceuticals Provides Corporate Updates and Reports Third Quarter 2023

6 Nov 23

Entry into a Material Definitive Agreement

2 Oct 23

424B5

Prospectus supplement for primary offering

2 Oct 23

424B5

Prospectus supplement for primary offering

28 Sep 23

8-K

Departure of Directors or Certain Officers

25 Sep 23

8-K

Departure of Directors or Certain Officers

14 Sep 23

8-K

Departure of Directors or Certain Officers

13 Sep 23

8-K

Madrigal Pharmaceuticals Announces NDA Acceptance and Priority Review of the New Drug

13 Sep 23

S-8

Registration of securities for employees

11 Sep 23

Transcripts

MDGL

Earnings call transcript

2022 Q1

9 May 22

Latest ownership filings

View all

BAKER BROS. ADVISORS LP

JANUS HENDERSON GROUP PLC

10 Oct 23

Financial summary

Financial statements Chart MDGL financial data

Quarter (USD)	Sep 23	Jun 23	Mar 23	Dec 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 22	Dec 21	Dec 20	Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	62.06 mm	62.06 mm	62.06 mm	62.06 mm	62.06 mm	62.06 mm
Cash burn (monthly)	5.05 mm	(no burn)	32.84 mm	29.05 mm	28.31 mm	25.23 mm
Cash used (since last report)	10.62 mm	n/a	69.09 mm	61.11 mm	59.54 mm	53.08 mm
Cash remaining	51.44 mm	n/a	-7.03 mm	944.28 k	2.51 mm	8.97 mm
Runway (months of cash)	10.2	n/a	-0.2	0.0	0.1	0.4

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2023

MDGL institutional ownership history Ownership history

93.6% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	206	214	-3.7%
Opened positions	34	36	-5.6%
Closed positions	42	48	-12.5%
Increased positions	87	87	–
Reduced positions	54	57	-5.3%

13F shares	Current	Prev Q	Change
Total value	2.46 tn	3.39 tn	-27.3%
Total shares	18.47 mm	16.27 mm	+13.6%
Total puts	323.80 k	689.60 k	-53.0%
Total calls	862.70 k	789.30 k	+9.3%
Total put/call ratio	0.4	0.9	-57.0%

Largest owners	Shares	Value	Change
JHG Janus Henderson	3.04 mm	$444.33 bn	+105.0%
Vanguard	1.57 mm	$229.77 bn	+7.4%
Avoro Capital Advisors	1.56 mm	$227.09 bn	+2.6%
Baker Bros. Advisors	1.55 mm	$225.65 bn	0.0%
Bay City Capital	1.51 mm	$117.96 mm	0.0%
BLK Blackrock	1.03 mm	$150.82 bn	-1.0%
STT State Street	642.27 k	$93.80 bn	+18.1%
Paulson & Co.	500.00 k	$73.02 bn	+42.8%
FMR	440.38 k	$64.31 bn	+26.2%
Marshall Wace	395.40 k	$57.74 bn	-14.2%

Largest transactions	Shares	Bought/sold	Change
JHG Janus Henderson	3.04 mm	+1.56 mm	+105.0%
Assenagon Asset Management	42.38 k	-424.39 k	-90.9%
Ra Capital Management	204.50 k	+204.50 k	NEW
Citadel Advisors	276.83 k	+192.92 k	+229.9%
Perceptive Advisors	124.64 k	-178.35 k	-58.9%
Point72 Asset Management	172.90 k	+172.90 k	NEW
Pictet Asset Management	0.00	-171.33 k	EXIT
Paulson & Co.	500.00 k	+149.80 k	+42.8%
T. Rowe Price	170.37 k	+114.97 k	+207.5%
Pictet Asset Management Holding	111.43 k	+111.43 k	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

MDGL insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
30 Nov 23	Brian Joseph Lynch	Common Stock	Sell	Dispose S	No	No	206.73	1,000	206.73 k	15,001
30 Nov 23	Brian Joseph Lynch	Common Stock	Sell	Dispose S	No	No	203	1,000	203.00 k	16,001
30 Nov 23	Brian Joseph Lynch	Common Stock	Sell	Dispose S	No	No	204	1,000	204.00 k	17,001
30 Nov 23	Brian Joseph Lynch	Common Stock	Option exercise	Acquire M	No	No	73.75	3,000	221.25 k	18,001
30 Nov 23	Brian Joseph Lynch	Stock Option Common Stock	Option exercise	Dispose M	No	No	73.75	3,000	221.25 k	18,000
29 Nov 23	Brian Joseph Lynch	Common Stock	Sell	Dispose S	No	No	199.45	3,000	598.35 k	15,001
29 Nov 23	Brian Joseph Lynch	Common Stock	Sell	Dispose S	No	No	198.4	1,000	198.40 k	18,001
29 Nov 23	Brian Joseph Lynch	Common Stock	Option exercise	Acquire M	No	No	73.75	4,000	295.00 k	19,001
29 Nov 23	Brian Joseph Lynch	Stock Option Common Stock	Option exercise	Dispose M	No	No	73.75	4,000	295.00 k	21,000
21 Nov 23	Baker Bros. Advisors	Common Stock	Buy	Acquire P	Yes	No	190.1361	7,917	1.51 mm	1,667,104